Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein SA pseudogene 13 (RPSAP13) is a processed pseudogene of the ribosomal protein SA (RPSA) gene in humans. It does not encode a functional protein. The parent gene, RPSA, codes for a ribosomal protein with additional functions as a laminin receptor and is involved in relevant pathological processes such as cancer metastasis, infection, and prion diseases. However, RPSAP13, as a pseudogene, is not known to play a direct biological role and is not considered a therapeutic target or biomarker. There is no evidence of disease relevance, drug interactions, or safety concerns related to this pseudogene.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein SA pseudogene 13 (RPSAP13).